Drugs Online |
 |
 | ||
|
Exelon Oral Solution Generic Rivastigmine |
|
| ||
Drugs Online » Prescription Drugs 7 » Exelon Oral Solution Generic Rivastigmine Rivastigmine is used to treat mild to moderate confusion (dementia) related to Alzheimer's disease. It is also used to treat mild to moderate confusion (dementia) related to Parkinson's disease. Rivastigmine does not cure either of these diseases but it may improve memory awareness and the ability to perform daily functions. This medication works by restoring the balance of natural substances (neurotransmitters) in the brain.Dementia of the Alzheimer's typeThe dosage of Exelon« (rivastigmine tartrate) shown to be effective in controlled clinical trials in Alzheimer's Disease is 6-12 mg/day given as twice-a-day dosing (daily doses of 3 to 6 mg BID). The starting dose of Exelon is 1.5 mg twice a day (BID). If this dose is well tolerated after a minimum of 2 weeks of treatment the dose may be increased to 3 mg BID. Subsequent increases to 4.5 mg BID and 6 mg BID should be attempted after a minimum of 2 weeks at the previous dose. If adverse effects (e.g. nausea vomiting abdominal pain loss of appetite) cause intolerance during treatment the patient should be instructed to discontinue treatment for several doses and then restart at the same or next lower dose level. If treatment is interrupted for longer than several days treatment should be reinitiated with the lowest daily dose and titrated as described above (see WARNINGS). The maximum dose is 6 mg BID (12 mg/day).Dementia associated with Parkinson's DiseaseThe dosage of Exelon« shown to be effective in the single controlled clinical trial conducted in dementia associated with Parkinson's Disease is 3 to 12 mg/day given as twice-a-day dosing (daily doses of 1.5 to 6 mg BID). In that medical condition the starting dose of Exelon« is 1.5 mg BID; subsequently the dose may be increased to 3 mg BID and further to 4.5 mg BID and 6 mg BID based on tolerability with a minimum of 4 weeks at each dose.Exelon should be taken with meals in divided doses in the morning and evening.Recommendations for Administration: Caregivers should be instructed in the correct procedure for administering Exelon Oral Solution. In addition they should be directed to the Instruction Sheet (included with the product) describing how the solution is to be administered. Caregivers should Online questions about the administration of the solution to either their physician or pharmacist. Patients should be instructed to remove the oral dosing syringe provided in its protective case and using the provided syringe withdraw the prescribed amount of Exelon Oral Solution from the container. Each dose of Exelon Oral Solution may be swallowed directly from the syringe or first mixed with a small glass of water cold fruit juice or soda. Patients should be instructed to stir and drink the mixture.Exelon Oral Solution and Exelon Capsules may be interchanged at equal doses. Buy Exelon Oral Solution Generic Rivastigmine and other Prescription Drugs 7 products online at Medstore. 5935
About Exelon Oral Solution Generic Rivastigmine: Product Type: Prescription Drugs 7 Exelon Oral Solution ( Generic Rivastigmine ) Exelon Oral Solution (Generic Rivastigmine) Generic Rivastigmine 2mg/mL 120mL Generic Rivastigmine Exelon Oral Solution
View more Prescription Drugs 7 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
